当中医药遇上人工智能，发展潜力有多大？ 专访省政协委员、省中医药管理局局长田兴军 省政协委员田兴军 今年，一台被称为"中医CT"的中医经络检测仪走进省两会现场，吸引了不少代表委员前去体验。 四川是中医药大省，素有"中医之乡、中药之库""无川药不成方"的美誉。今年的省政府工作报告提出， 建好用好国家中医药综合改革示范区，推进中医药事业产业文化"三位一体"高质量发展。"十五五"开局 之年，四川中医药将如何高质量发展？老百姓又能从中获得哪些实惠？2月2日，华西都市报、封面新闻 记者专访了省政协委员，四川省中医药管理局党组书记、局长田兴军。 拥抱科技 中医药在AI领域大有可为 四川省中医药管理局正会同省医保局，在国家试点基础上，结合本省实际，制定四川省中医优势病种按 病种付费目录，遵循"中医优势明显、诊疗路径清晰、费用相对稳定"原则，优先纳入具有中医特色的病 种，如桡骨远端骨折、踝关节扭伤等，并动态调整病种范围。通过医保支付方式改革，推动中医医疗机 构优化服务流程，降低群众就医负担，同时激励中医药特色技术传承创新。 下一步，两部门将进一步完善配套政策，明确中医优势病种的诊断标准、疗效评价指标和医保支付标 准，探索中医 ...

记者 田小东 责任编辑：任彩玲 该系统依托全国名中医张志明的数千份优质门诊舌象数据，深度挖掘两万余份临床病案，集成舌诊辅 助、导诊挂号、院内导航、智能问答四大核心模块。以"舌领四诊，以舌测证，数融中西，循证精准"为 核心理念，融合名老中医舌诊经验与人工智能技术，构建起精准高效的舌诊辨证模型，实现技术与临床 的深度融合，打破了传统技术简单叠加的局限。 系统兼具便民与助医双重价值：对群众，大幅优化就医流程，让中医药服务更便捷贴心，真正实现"数 据多跑路、群众少跑腿"；对医师，尤其为青年医师提供"辨证、立法、选方、审方"全流程智能辅助， 助力中医诊疗规范化、标准化建设。 作为我省中医药传承创新的重要里程碑，"陇上小郎中"具备可复制性与可及性，可通过互联网医院、医 联体等渠道下沉优质资源。其不仅为甘肃中医药数字化转型提供了特色方案，更推动中医药从"经验主 导"迈向"数据赋能"新阶段，为中西医与人工智能深度融合探索了可行路径，对引领全省中医药数字 化、智能化转型具有重要示范意义。 "陇上小郎中"中医药AI辅助诊疗系统正式发布 每日甘肃网1月21日讯 据兰州晚报报道 日前，甘肃省中医药数字化平台核心成果"陇上小郎中"中医 ...

Core Insights - Beijing University of Chinese Medicine Shenzhen Hospital (Longgang) inaugurated its new surgical inpatient building and educational building, which is part of Longgang District's "14th Five-Year Plan" for public welfare, increasing the total number of hospital beds to 1,100 [1][2] Group 1: Hospital Development - The new buildings include a 23-story surgical inpatient building and a 13-story educational building, covering an area of approximately 13,000 square meters with an additional construction area of about 96,000 square meters [1] - The hospital will add 600 new medical beds, bringing the total to 1,100 upon full operation [1] Group 2: Specialized Departments - The surgical inpatient building features specialized wards for gynecology, pain management, nephrology, liver disease, gastrointestinal disorders, proctology, orthopedic injuries, rehabilitation, neurosurgery, and brain diseases [2] - The hospital has established one national advantageous specialty, six provincial key (specialty) clinical specialties, seven municipal key (specialty) specialties, and five district-level key disciplines [2] Group 3: AI Integration - The AI + Traditional Chinese Medicine (TCM) clinic combines classical TCM theories with AI technology to create a standardized, intelligent, and traceable health service support platform [3] - The AI + TCM clinic employs a "human-machine collaboration" approach for consultations, where AI assists in pre-diagnosis and integrates information for personalized treatment recommendations [3] - The hospital signed strategic cooperation agreements with six enterprises from Shenzhen, Hong Kong, and Macau, focusing on projects like AI orthopedic robots and TCM multimodal big data platforms [3]

Core Viewpoint - Yiling Pharmaceutical has launched its self-developed innovative traditional Chinese medicine, Qifang Nasal Tablets, for the treatment of persistent allergic rhinitis, providing a new treatment option for millions of patients in China [1][6]. Group 1: Product Information - Qifang Nasal Tablets are classified as a national Class 1.1 innovative traditional Chinese medicine and have received national invention patents and support from provincial and ministerial key research projects [3]. - The product is based on the clinical experience of Professor Li Shuliang from the Chinese Academy of Medical Sciences and incorporates elements from classic formulas "Yupingfeng San" and "Xinyi San" [6]. - Clinical trials showed a total effective rate of 89% after four weeks of treatment, with significant improvements in nasal and eye symptoms compared to the control group [6]. Group 2: Market Context - Allergic rhinitis is a common chronic disease in China, with a self-reported prevalence rate of 17.6%, indicating that approximately 1 in 6 people suffers from this condition [1]. - The demand for safe, effective, and long-term treatment options is urgent among patients suffering from allergic rhinitis [1]. Group 3: Collaboration and Distribution - Yiling Pharmaceutical has partnered with Alibaba Health to leverage its digital service capabilities for the comprehensive market launch of Qifang Nasal Tablets [6][7]. - Alibaba Health aims to enhance disease knowledge dissemination and improve drug accessibility through its nationwide distribution network [7].

Core Viewpoint - The launch of the AI-driven smart factory by Hongjitang marks a significant milestone in the digital and intelligent transformation of traditional Chinese medicine, aiming to set a new benchmark for smart production in the industry [1] Group 1: Technological Innovation - The smart factory integrates AI technologies, achieving a new breakthrough in "manufacturing intelligence" by implementing an AI prescription analysis system, intelligent dispensing models, and AI models for pill production [3] - The factory's automation rate has significantly increased to 91%, enhancing production efficiency while ensuring product quality and stability, thus achieving a dual improvement in efficiency and quality [3] Group 2: Drug Safety and Quality Control - A comprehensive digital traceability system has been established, covering the entire lifecycle from herb planting to patient medication, utilizing advanced industrial internet and blockchain technologies [4] - The system automatically collects and associates 35 key traceability indicators, allowing patients to scan a QR code for real-time access to information about the source of medicinal materials and quality inspection reports [4] Group 3: Sustainable Development - The project adopts a green low-carbon development approach, including an energy recycling system that effectively reuses steam generated during the cooking process [5] - The implementation of an efficient drone delivery system significantly improves delivery times, especially for emergency medications, with a time reduction of 83% compared to traditional methods [5] - These green initiatives are projected to reduce carbon emissions by approximately 86 tons annually, establishing a sustainable development model in the traditional Chinese medicine industry [5] Group 4: Service Innovation - The launch event included a live demonstration of low-altitude delivery services in collaboration with Guang'anmen Hospital and Jinan Hospital, enhancing the efficiency of drug delivery, particularly for emergency and elderly patients [7] - This initiative represents a new scenario for smart delivery in traditional Chinese medicine, showcasing Hongjitang's commitment to innovation in healthcare services [7] Group 5: Future Outlook - Hongjitang aims to continue leveraging cutting-edge technologies such as AI and big data to promote the modernization, intelligence, and internationalization of traditional Chinese medicine [7]

Core Insights - The forum titled "AI Empowering High-Quality Development of Traditional Chinese Medicine" was held in Hefei, focusing on the integration of artificial intelligence (AI) with traditional Chinese medicine (TCM) [2][3] - Over 600 participants, including government officials, industry leaders, and experts, gathered to discuss innovative development paths for TCM through AI [2][3] Group 1: Forum Highlights - The forum featured a speech by Zhu Xianfa, emphasizing the strategic significance of AI in promoting high-quality development in TCM and the need for innovative thinking [3] - Key activities included the joint awarding of 17 provincial TCM social organizations, marking the establishment of a collaborative innovation ecosystem [3] - The establishment of the Anhui Digital TCM Alliance was announced, focusing on data sharing, AI technology collaboration, and research outcome transformation [3] Group 2: Expert Presentations - Liu Liang, an academician, presented on how AI can reconstruct TCM research methodologies and enhance its clinical value [4] - A report from the National Administration of Traditional Chinese Medicine discussed the policy implications of promoting digital TCM development [4] - Li Candong provided insights into the development and application of an intelligent TCM health management system, showcasing its potential in personalized health management [4] Group 3: Future Directions - The forum adopted a dual-location model in Hefei and Bozhou, featuring four specialized sub-forums on various topics related to AI and TCM [5] - The discussions aimed to create a collaborative platform for government, industry, academia, and research, focusing on AI TCM diagnostic technology and digital standardization [5] - Future initiatives will continue to integrate resources, promote TCM culture, and foster innovation in the TCM industry [5]

Core Viewpoint - Traditional Chinese medicine (TCM) products are increasingly recognized globally, becoming an important representation of China in international relations, supported by strong policy initiatives [1][2]. Policy Guidance - The strategic significance of TCM service trade in the context of globalization was emphasized by various speakers at the forum, highlighting the need for high-quality development to deepen TCM's internationalization and participation in global health governance [2]. - The Ministry of Commerce has recognized 31 national TCM service export bases and introduced 18 specific support policies to enhance TCM service trade, focusing on platform development, talent training, standard formulation, and market expansion [2][3]. Development Initiatives - The Ministry of Commerce plans to formulate new goals and policies for promoting TCM service trade, aligning with national strategies like the Belt and Road Initiative to expand the scale of TCM service trade [3]. - Beijing has established itself as a key area for TCM service trade, with 1,340 TCM medical institutions and three national TCM service export bases by the end of 2024, enhancing international influence and service capabilities [4]. Standardization Efforts - The forum launched a research report on TCM service trade and initiated a group standard for the "Guidelines for International TCM Medical Services," aimed at creating a scientifically recognized standard system for TCM services [5]. - The lack of standardized practices has been a barrier to TCM's internationalization, and the new guidelines are expected to provide a benchmark for TCM medical institutions globally, ensuring safety and efficacy [5]. Digital Transformation - Digitalization is emerging as a new engine for TCM service trade, with remote medical services, online education, and digital platforms facilitating TCM's international outreach [6]. - The aging global population presents challenges, and the integration of TCM with the elderly care economy is seen as a significant opportunity to leverage TCM's unique advantages in preventive care and rehabilitation [6].

Core Viewpoint - Traditional Chinese medicine (TCM) products are increasingly recognized globally, becoming an important symbol of China's connection with the international community, supported by strong policy initiatives [1][3]. Policy Guidance - TCM has demonstrated unique clinical efficacy in areas such as health maintenance and chronic disease management, emphasizing its strategic significance in global health [3]. - The Ministry of Commerce has recognized TCM service trade as a key area for promoting new momentum in foreign trade, with 31 national TCM service export bases established and 18 supportive policies implemented [4][3]. Development Measures - A notification issued by multiple government departments outlines 18 specific measures to support the high-quality development of TCM service export bases, focusing on improving the development environment and fostering international cooperation [4]. - The Ministry of Commerce plans to develop new goals and policies for TCM service trade, aligning with national strategies like the Belt and Road Initiative [4]. Regional Experience - Beijing has established itself as a key area for TCM service trade, with 1,340 TCM medical institutions and three national TCM service export bases by the end of 2024 [5]. Standardization Efforts - The launch of the "Guidelines for International Medical Services in TCM" aims to create a standardized and internationally recognized framework for TCM services, addressing the lack of standards that has hindered TCM's internationalization [6]. - Digitalization is emerging as a new engine for TCM service trade, with remote medical services and online education enhancing international accessibility [6]. Market Opportunities - The growth of service trade exports has outpaced goods trade, with significant potential in medical tourism and the integration of TCM with cross-border healthcare [7]. - The "TCM + Silver Economy" model is identified as having great potential to address global aging challenges, leveraging TCM's strengths in preventive care and rehabilitation [7]. Collaborative Development - High-quality development of TCM service trade requires collaboration among various stakeholders, including government, industry organizations, and enterprises, to overcome systemic barriers and enhance service capabilities [7]. International Cooperation - Agreements signed between Chinese institutions and international partners aim to promote the global application of TCM technology and services [8]. - With ongoing policy support and digital integration, TCM service trade is expected to become a new growth driver for China's service exports, contributing significantly to global health governance [8].

Core Viewpoint - Traditional Chinese medicine (TCM) products are increasingly recognized globally, becoming an important symbol of China's connection with the international community, supported by strong policy initiatives [1][3]. Policy Guidance - TCM has demonstrated unique clinical efficacy in areas such as health maintenance and chronic disease management, emphasizing its strategic significance in global health [3]. - The Ministry of Commerce has recognized 31 national TCM service export bases and introduced 18 supportive policies to enhance TCM service trade [4]. Development Measures - A notification issued in 2021 outlines 18 specific measures to support the high-quality development of TCM service export bases, focusing on improving the development environment and fostering international cooperation [4]. - Beijing has established itself as a key area for TCM service trade, with 1,340 TCM medical institutions and three national TCM service export bases by the end of 2024 [5]. Standardization and Digitalization - The launch of the "Guidelines for International Medical Services in TCM" aims to create a standardized and internationally recognized TCM service framework, addressing the lack of standards that hinders TCM's internationalization [6]. - Digitalization is becoming a new engine for TCM service trade, with remote medical services and online education enhancing international accessibility [6]. Market Opportunities - The export growth rate of service trade has surpassed that of goods trade, indicating significant potential for TCM in the medical tourism sector [7]. - The integration of TCM with the aging population's needs presents a unique opportunity to develop a health service system tailored to global aging challenges [7]. Collaborative Efforts - A consensus among representatives from government and industry organizations highlights the necessity for collaborative efforts to enhance the quality of TCM service trade [7]. - Recent agreements between Chinese institutions and international partners aim to facilitate the global implementation of TCM technology services [8].

Core Viewpoint - The 2025 China International Service Trade Fair (CIFTIS) will focus on health and wellness services, featuring advanced technologies and innovations in the integration of artificial intelligence and healthcare, with the theme "Intelligent Leading the Future, Healthy Living" [1][3]. Group 1: Event Overview - The CIFTIS will take place from September 10 to 14 in Beijing, showcasing two main exhibition areas: "Intelligent Therapy Cloud Matrix" and "Universal Health Service Matrix" [1][3]. - The event will host nearly 20 conferences and forums, including the Capital International Medical Conference [5][6]. Group 2: Exhibition Highlights - The health service exhibition will feature a total participation rate of 54% from Fortune 500 and industry-leading companies, with an international participation rate of 53% [3]. - The "Intelligent Therapy Cloud Matrix" will present 15 stages of AI-driven biomedical research and development, highlighting advanced cases such as diagnostic models and AI result transformation [3]. Group 3: Focus Areas - The "Universal Health Service Matrix" will cover health management, elderly care, and traditional Chinese medicine, offering public health lectures and showcasing innovative projects from Beijing's medical institutions [4]. - The event will also emphasize the "Beijing Service" brand case studies [4]. Group 4: International Collaboration and Innovation - The Capital International Medical Conference will include discussions on technology innovation, healthcare industry development, and international cooperation, featuring renowned experts and institutions [6]. - The conference will release significant research findings, including the "BMJ China Hospital Clinical Research International Influence Report" and the "Digital Medical Blue Book" [6]. Group 5: Traditional Chinese Medicine (TCM) Initiatives - The TCM theme will feature 48 participating institutions, with 27 exhibiting offline, marking a record high for participation from leading TCM organizations [7]. - The event will include four TCM-themed forums and a policy seminar, focusing on international development and digitalization of TCM [7][8].